The global pharmaceutical intermediates market is expected to grow at a CAGR of 4.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for pharmaceutical intermediates in emerging economies such as China and India. The growing demand for antibiotics, antipyretic analgesics, vitamins, and other drugs in these countries has led to an increase in the production of pharmaceutical intermediates.
The global pharmaceutical intermediates market by type is segmented into GMP and noGMP products. GMP products are used as raw materials for manufacturing drugs that are approved by regulatory authorities such as FDA or EMA whereas noGMP products are not approved by any regulatory authority but can be used for manufacturing drugs that do not require approval from regulatory authorities such as over-the-counter (OTC) medicines or dietary supplements. The GMP segment accounted for a share of more than 50% in 2018 owing to its high demand among manufacturers who produce drugs that require approval from regulatory authorities before they can be sold commercially.
6. For instance, Pfizer invested $8 billion into R&D activities during 2016-2017 which is expected to increase its share in this segment.
- The global pharmaceutical intermediates market is expected to grow at a CAGR of 4.5% from 2017 to 2022.
- The growth of the global pharmaceutical intermediates market is driven by factors such as increasing demand for generic drugs and rising prevalence of chronic diseases in developing countries.
- Increasing demand for generic drugs will drive the growth of the global pharmaceutical intermediates market over the forecast period owing to their lower prices and increased accessibility in developing countries with high rates of chronic diseases such as diabetes and cancer.
- In addition, increasing prevalence of chronic diseases in developing countries will also drive the growth of this market over the forecast period due to their higher incidence rates than developed economies.
- Increasing investments by major players in research and development activities will also fuel this market's growth over the forecast period.
Industry Growth Insights published a new data on “Pharmaceutical Intermediates Market”. The research report is titled “Pharmaceutical Intermediates Market research by Types (GMP, Non-GMP, ), By Applications (Antibiotics, Antipyretic Analgesics, Vitamins, Others, ), By Players/Companies Lonza, Catalent, Patheon, Jubilant, Granules, Ganesh, Chemcon, BASF, Porton, Lianhetech, ABA Chem, Tianma, Jiujiujiu, Alpha, Jiuzhou, Yongtai”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Intermediates Market Research Report
By Type
GMP, Non-GMP,
By Application
Antibiotics, Antipyretic Analgesics, Vitamins, Others,
By Companies
Lonza, Catalent, Patheon, Jubilant, Granules, Ganesh, Chemcon, BASF, Porton, Lianhetech, ABA Chem, Tianma, Jiujiujiu, Alpha, Jiuzhou, Yongtai
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Intermediates Market Report Segments:
The global Pharmaceutical Intermediates market is segmented on the basis of:
Types
GMP, Non-GMP,
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Antibiotics, Antipyretic Analgesics, Vitamins, Others,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Lonza
- Catalent
- Patheon
- Jubilant
- Granules
- Ganesh
- Chemcon
- BASF
- Porton
- Lianhetech
- ABA Chem
- Tianma
- Jiujiujiu
- Alpha
- Jiuzhou
- Yongtai
Highlights of The Pharmaceutical Intermediates Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- GMP
- Non-GMP
- By Application:
- Antibiotics
- Antipyretic Analgesics
- Vitamins
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Intermediates Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmaceutical intermediates are chemicals used in the production of pharmaceuticals. These chemicals can be found in a variety of forms, including liquids, powders, and tablets. Pharmaceutical intermediates are often used to create new drugs or to improve existing drugs.
Some of the key players operating in the pharmaceutical intermediates market are Lonza, Catalent, Patheon, Jubilant, Granules, Ganesh, Chemcon, BASF, Porton, Lianhetech, ABA Chem, Tianma, Jiujiujiu, Alpha, Jiuzhou, Yongtai.
The pharmaceutical intermediates market is expected to grow at a compound annual growth rate of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pharmaceutical Intermediates Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pharmaceutical Intermediates Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pharmaceutical Intermediates Market - Supply Chain
4.5. Global Pharmaceutical Intermediates Market Forecast
4.5.1. Pharmaceutical Intermediates Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pharmaceutical Intermediates Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pharmaceutical Intermediates Market Absolute $ Opportunity
5. Global Pharmaceutical Intermediates Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pharmaceutical Intermediates Market Size and Volume Forecast by Type
5.3.1. GMP
5.3.2. Non-GMP
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pharmaceutical Intermediates Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pharmaceutical Intermediates Market Size and Volume Forecast by Application
6.3.1. Antibiotics
6.3.2. Antipyretic Analgesics
6.3.3. Vitamins
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pharmaceutical Intermediates Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pharmaceutical Intermediates Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pharmaceutical Intermediates Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pharmaceutical Intermediates Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pharmaceutical Intermediates Demand Share Forecast, 2019-2026
9. North America Pharmaceutical Intermediates Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pharmaceutical Intermediates Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pharmaceutical Intermediates Market Size and Volume Forecast by Application
9.4.1. Antibiotics
9.4.2. Antipyretic Analgesics
9.4.3. Vitamins
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pharmaceutical Intermediates Market Size and Volume Forecast by Type
9.7.1. GMP
9.7.2. Non-GMP
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pharmaceutical Intermediates Demand Share Forecast, 2019-2026
10. Latin America Pharmaceutical Intermediates Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pharmaceutical Intermediates Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pharmaceutical Intermediates Market Size and Volume Forecast by Application
10.4.1. Antibiotics
10.4.2. Antipyretic Analgesics
10.4.3. Vitamins
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pharmaceutical Intermediates Market Size and Volume Forecast by Type
10.7.1. GMP
10.7.2. Non-GMP
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pharmaceutical Intermediates Demand Share Forecast, 2019-2026
11. Europe Pharmaceutical Intermediates Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pharmaceutical Intermediates Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pharmaceutical Intermediates Market Size and Volume Forecast by Application
11.4.1. Antibiotics
11.4.2. Antipyretic Analgesics
11.4.3. Vitamins
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pharmaceutical Intermediates Market Size and Volume Forecast by Type
11.7.1. GMP
11.7.2. Non-GP
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pharmaceutical Intermediates Demand Share, 2019-2026
12. Asia Pacific Pharmaceutical Intermediates Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pharmaceutical Intermediates Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pharmaceutical Intermediates Market Size and Volume Forecast by Application
12.4.1. Antibiotics
12.4.2. Antipyretic Analgesics
12.4.3. Vitamins
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pharmaceutical Intermediates Market Size and Volume Forecast by Type
12.7.1. GMP
12.7.2. Non-GMP
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pharmaceutical Intermediates Demand Share, 2019-2026
13. Middle East & Africa Pharmaceutical Intermediates Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pharmaceutical Intermediates Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pharmaceutical Intermediates Market Size and Volume Forecast by Application
13.4.1. Antibiotics
13.4.2. Antipyretic Analgesics
13.4.3. Vitamins
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pharmaceutical Intermediates Market Size and Volume Forecast by Type
13.7.1. GMP
13.7.2. Non-GMP
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pharmaceutical Intermediates Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pharmaceutical Intermediates Market: Market Share Analysis
14.2. Pharmaceutical Intermediates Distributors and Customers
14.3. Pharmaceutical Intermediates Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Lonza
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Catalent
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Patheon
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Jubilant
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Granules
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Ganesh
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Chemcon
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. BASF
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Porton
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Lianhetech
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. ABA Chem
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Tianma
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Jiujiujiu
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Alpha
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Jiuzhou
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Yongtai
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
